Interim report January – September 2021
(Oslo, 9 November 2021) Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the period January 1 – September 30, 2021. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Genetic Analysis CEO Ronny Hermansen comments:“We see the microbiome as a gamechanger in health and medicine moving forward. The Company’s recent financial injection paired up with our pioneering technology puts GA in an excellent position to realize our goal of being at the forefront of microbiome diagnostics